Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Cardio Diagnostics Holdings Inc. - Common stock
(NQ:
CDIO
)
0.3449
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 2, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cardio Diagnostics Holdings Inc. - Common stock
< Previous
1
2
3
4
5
6
7
8
Next >
Spotlight: Healthcare and Tech VTAK, ORGO, CDIO, LAZR, VLCN
May 13, 2024
Via
AB Newswire
Cardio Diagnostics Holdings, Inc. Announces the Availability of Its Clinical Tests at Family Medicine Specialists’ Retail Healthcare Clinic at Walmart Supercenter in Round Lake Beach, Illinois, That Offers Walk-In Appointments Seven Days a Week
May 13, 2024
From
Cardio Diagnostics Holdings, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Friday's Intraday Session
May 10, 2024
Via
Benzinga
BlackRock Acquires Stake In Cardio Diagnostics
February 09, 2024
--News Direct--
Via
News Direct
New Study Shows Cardio Diagnostics’ (NASDAQ: CDIO) PrecisionCHD Test Could Save Health Insurers Over $113 Million Annually
May 07, 2024
New Study Shows Cardio Diagnostics’ (NASDAQ: CDIO) PrecisionCHD Test Could Save Health Insurers Over $113 Million Annually
Via
News Direct
New Study Shows Cardio Diagnostics’ (NASDAQ: CDIO) PrecisionCHD Test Could Save Health Insurers Over $113 Million Annually
May 07, 2024
By Jeremy Golden, Benzinga
Via
TheNewswire.com
Cardio Diagnostics Announces Publication of Study Showing That its PrecisionCHD™ Test Could Save Health Insurers Over $113 Million Annually
April 29, 2024
From
Cardio Diagnostics Holdings, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Friday's Intraday Session
April 19, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
April 15, 2024
Via
Benzinga
Cardio Diagnostics Inks Groundbreaking Telehealth Agreement With Navierre And Expands Access To Cardiovascular Tests
April 12, 2024
Cardio Diagnostics Inks Groundbreaking Telehealth Agreement With Navierre And Expands Access To Cardiovascular Tests
Via
News Direct
Exponential Health Partners with Cardio Diagnostics to Elevate Cardiovascular Disease Prevention in Michigan
April 09, 2024
From
Cardio Diagnostics Holdings, Inc.
Via
Business Wire
CDIO Stock Earnings: Cardio Diagnostics Hldgs Misses Revenue for Q4 2023
April 04, 2024
CDIO stock results show that Cardio Diagnostics Hldgs missed on revenue for the fourth quarter of 2023.
Via
InvestorPlace
Cardio Diagnostics Holdings, Inc. Enters Into a Nationwide Telehealth Agreement with Navierre
April 04, 2024
From
Cardio Diagnostics Holdings, Inc.
Via
Business Wire
Cardio Diagnostics Holdings, Inc. to Showcase HeartRisk and Actionable Clinical Intelligence Version 3 at the American College of Cardiology’s 73rd Annual Scientific Session
March 14, 2024
From
Cardio Diagnostics Holdings, Inc.
Via
Business Wire
BlackRock Bolsters Wealth Management Arsenal With SpiderRock Advisors Acquisition, Expanding SMA Solutions
March 08, 2024
BlackRock (NYSE: BLK) to acquire full ownership of SpiderRock Advisors, expanding offerings in customized option overlay strategies for U.S. wealth market.
Via
Benzinga
Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
March 05, 2024
Shares of SOPHiA GENETICS SA (NASDAQ: SOPH) fell sharply during Tuesday’s session after the company reported worse than expected fourth-quarter earnings and issued 2024 guidance.
Via
Benzinga
Cardio Diagnostics Holdings, Inc. Announces Issuance of Second U.S. Patent for Compositions and Methods for Detecting Predisposition to Cardiovascular Disease
March 05, 2024
From
Cardio Diagnostics Holdings, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Friday's Pre-Market Session
February 16, 2024
Via
Benzinga
Cardio Diagnostics Holdings, Inc. Expands HeartRisk™ Platform Offering to Diverse Markets in Conjunction with Nationwide Rollout
February 15, 2024
From
Cardio Diagnostics Holdings, Inc.
Via
Business Wire
Cardio Diagnostics (NASDAQ: CDIO) Expands Partnership With Family Medicine Specialists To Bring Specialty Cardiology Tests To Select Walmart Supercenters
February 15, 2024
--News Direct--
Via
News Direct
Cardio Diagnostics (NASDAQ: CDIO) Expands Partnership With Family Medicine Specialists To Bring Specialty Cardiology Tests To Select Walmart Supercenters
February 14, 2024
A precision cardiovascular medicine company’s innovative AI-driven epigenetic-genetic blood tests will soon be available in one of the nation’s largest retailers.
Via
Benzinga
BlackRock Acquires Stake In Cardio Diagnostics
February 08, 2024
BlackRock (NYSE: BLK) has acquired a minor stake in Cardio Diagnostics (NASDAQ: CDIO), an artificial intelligence-powered precision cardiovascular medicine company. In BlackRock’s 13G filing on Feb.
Via
Benzinga
Cardio Diagnostics Holdings, Inc. Expands Partnership with Family Medicine Specialists to Bring Its Specialty Cardiology Tests to Select Walmart Supercenters
February 07, 2024
From
Cardio Diagnostics Holdings, Inc.
Via
Business Wire
Houston-Based resTOR Longevity Clinic to Offer Cardio Diagnostics' AI-Driven Epigenetic-Genetic Heart Disease Tests
February 05, 2024
From
Cardio Diagnostics Holdings, Inc.
Via
Business Wire
American Medical Association Grants Cardio Diagnostics (NASDAQ: CDIO) Reimbursement Codes For AI-Powered Coronary Heart Disease Tests
January 30, 2024
By Jeremy Golden, Benzinga
Via
TheNewswire.com
Topics
Death
Exposures
Death
American Medical Association Grants Cardio Diagnostics (NASDAQ: CDIO) Reimbursement Codes For AI-Powered Coronary Heart Disease Tests
January 30, 2024
--News Direct--
Via
News Direct
American Medical Association Grants Cardio Diagnostics (NASDAQ: CDIO) Reimbursement Codes For AI-Powered Coronary Heart Disease Tests
January 29, 2024
Cardio Diagnostics’ AI-driven coronary heart disease (CHD) tests have taken another promising step in their evolution.
Via
Benzinga
Cardio Diagnostics Holdings, Inc. Accelerates Cardiac Care Innovation with Appointment of Dr. Vimal Ramjee as Strategic Advisor
January 24, 2024
From
Cardio Diagnostics Holdings, Inc.
Via
Business Wire
Beyond Diagnosis: Cardio Diagnostics' Actionable Clinical Intelligence Platform Provides Personalized Insights To Help Prevent Heart Attacks
January 09, 2024
By Jeremy Golden, Benzinga
Via
TheNewswire.com
Beyond Diagnosis: Cardio Diagnostics' Actionable Clinical Intelligence Platform Provides Personalized Insights To Help Prevent Heart Attacks
January 09, 2024
--News Direct--
Via
News Direct
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.